Navigation Links
inVentiv Health Reports Record Financial Results for Fourth Quarter and Full Year 2007
Date:2/28/2008

impairment charges from marketable securities, and non-recurring tax adjustments.

Conference Call Information

Thursday, February 28, 2008, 9:00 a.m. Eastern Time

Call in number: (800) 358-8448 (Domestic) or (706) 634 1367(International)

Live and archived webcast: http://www.inventivhealth.com

A replay of the call will be available immediately following the call through March 6, 2008 at (800) 642-1687 or (706) 645-9291. The conference ID number for the replay is 32253136.

In concert with the call, information regarding inVentiv Health's historical and recent operational and financial performance will be available at http://www.inVentivHealth.com/health/investorRelations/investorDecks.asp.

About inVentiv Health

inVentiv Health, Inc. (Nasdaq: VTIV) is an insights-driven global healthcare leader that provides dynamic solutions to deliver customer and patient success. inVentiv delivers its customized clinical, sales, marketing and communications solutions through its four core business segments: inVentiv Clinical, inVentiv Communications, inVentiv Commercial, and inVentiv Patient Outcomes. inVentiv Health's client roster is comprised of more than 325 leading pharmaceutical, biotech, life sciences and healthcare payor companies, including all top 20 global pharmaceutical manufacturers. For more information, visit http://www.inVentivHealth.com.

(1) USE OF NON-GAAP FINANCIAL MEASURES

This press release contains non-GAAP financial measures which is intended to make the
'/>"/>

SOURCE inVentiv Health, Inc.
Copyright©2008 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15

Related medicine news :

1. inVentiv Health Ranked #17 by Training Magazine in its 2008 List of Top 125 Training Companies
2. inVentiv Health to Announce Fourth Quarter and Full Year 2007 Results and Conduct Conference Call on Thursday, February 28th
3. inVentiv Health Provides Updated Information on December 11th Investor Day
4. inVentiv Health Creates Client Development and Integration Team
5. inVentiv Health to Present at the 2007 Credit Suisse Healthcare Conference
6. inVentiv Health Launches Fourth Business Segment: inVentiv Patient Outcomes
7. inVentiv Health to Announce Third Quarter Results and Conduct Conference Call on Wednesday, November 7, 2007
8. inVentiv Health to Present at the 20th Annual Bear Stearns Healthcare Conference
9. Crdentia Selected by Leading Staffing Vendor to Provide Health Care Staffing Services to One of the Largest Hospital Chains in the U.S.
10. Former Blue Cross/Blue Shield Account Manager Sentenced for Health Care Fraud Scheme, Tax Evasion
11. UCLA launches network to study health care disparities affecting minorities
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine Technology:Frost & Sullivan: Western European Markets Confirm Undisputed Convenience and Cost Benefit of Custom Procedure Trays 2Frost & Sullivan: Western European Markets Confirm Undisputed Convenience and Cost Benefit of Custom Procedure Trays 3Frost & Sullivan: Western European Markets Confirm Undisputed Convenience and Cost Benefit of Custom Procedure Trays 4$232 Billion Personalized Medicine Market to Grow 11 Percent Annually, says PricewaterhouseCoopers 2$232 Billion Personalized Medicine Market to Grow 11 Percent Annually, says PricewaterhouseCoopers 3$232 Billion Personalized Medicine Market to Grow 11 Percent Annually, says PricewaterhouseCoopers 4$232 Billion Personalized Medicine Market to Grow 11 Percent Annually, says PricewaterhouseCoopers 5$232 Billion Personalized Medicine Market to Grow 11 Percent Annually, says PricewaterhouseCoopers 6Inability of Pixantrone to Form Toxic Iron Complexes Results in Significant Reduction in Cardiac Cell Toxicity Compared to Currently Marketed Anthracyclines 2Inability of Pixantrone to Form Toxic Iron Complexes Results in Significant Reduction in Cardiac Cell Toxicity Compared to Currently Marketed Anthracyclines 3Inability of Pixantrone to Form Toxic Iron Complexes Results in Significant Reduction in Cardiac Cell Toxicity Compared to Currently Marketed Anthracyclines 4National Alliance for Hispanic Health Applauds Confirmation of Sonia Sotomayor as the Nations 111th Supreme Court Justice 53920 1The Ensign Group Reports Second Quarter 2009 Earnings of 240 39 per Share 3B Reaffirms 2009 EPS Guidance 53917 1The Ensign Group Reports Second Quarter 2009 Earnings of 240 39 per Share 3B Reaffirms 2009 EPS Guidance 53917 2The Ensign Group Reports Second Quarter 2009 Earnings of 240 39 per Share 3B Reaffirms 2009 EPS Guidance 53917 3The Ensign Group Reports Second Quarter 2009 Earnings of 240 39 per Share 3B Reaffirms 2009 EPS Guidance 53917 4The Ensign Group Reports Second Quarter 2009 Earnings of 240 39 per Share 3B Reaffirms 2009 EPS Guidance 53917 5The Ensign Group Reports Second Quarter 2009 Earnings of 240 39 per Share 3B Reaffirms 2009 EPS Guidance 53917 6The Ensign Group Reports Second Quarter 2009 Earnings of 240 39 per Share 3B Reaffirms 2009 EPS Guidance 53917 7The Ensign Group Reports Second Quarter 2009 Earnings of 240 39 per Share 3B Reaffirms 2009 EPS Guidance 53917 8The Ensign Group Reports Second Quarter 2009 Earnings of 240 39 per Share 3B Reaffirms 2009 EPS Guidance 53917 9The Ensign Group Reports Second Quarter 2009 Earnings of 240 39 per Share 3B Reaffirms 2009 EPS Guidance 53917 10The Ensign Group Reports Second Quarter 2009 Earnings of 240 39 per Share 3B Reaffirms 2009 EPS Guidance 53917 11The Ensign Group Reports Second Quarter 2009 Earnings of 240 39 per Share 3B Reaffirms 2009 EPS Guidance 53917 12The Ensign Group Reports Second Quarter 2009 Earnings of 240 39 per Share 3B Reaffirms 2009 EPS Guidance 53917 13Cogdell Spencer Inc Reports Second Quarter 2009 Financial Results 53914 1Cogdell Spencer Inc Reports Second Quarter 2009 Financial Results 53914 2Cogdell Spencer Inc Reports Second Quarter 2009 Financial Results 53914 3Cogdell Spencer Inc Reports Second Quarter 2009 Financial Results 53914 4Cogdell Spencer Inc Reports Second Quarter 2009 Financial Results 53914 5Cogdell Spencer Inc Reports Second Quarter 2009 Financial Results 53914 6Cogdell Spencer Inc Reports Second Quarter 2009 Financial Results 53914 7Cogdell Spencer Inc Reports Second Quarter 2009 Financial Results 53914 8Cogdell Spencer Inc Reports Second Quarter 2009 Financial Results 53914 9Cogdell Spencer Inc Reports Second Quarter 2009 Financial Results 53914 10Cogdell Spencer Inc Reports Second Quarter 2009 Financial Results 53914 11Cogdell Spencer Inc Reports Second Quarter 2009 Financial Results 53914 12Cogdell Spencer Inc Reports Second Quarter 2009 Financial Results 53914 13Cogdell Spencer Inc Reports Second Quarter 2009 Financial Results 53914 14Cogdell Spencer Inc Reports Second Quarter 2009 Financial Results 53914 15Cogdell Spencer Inc Reports Second Quarter 2009 Financial Results 53914 16Cogdell Spencer Inc Reports Second Quarter 2009 Financial Results 53914 17Cogdell Spencer Inc Reports Second Quarter 2009 Financial Results 53914 18Cogdell Spencer Inc Reports Second Quarter 2009 Financial Results 53914 19Cogdell Spencer Inc Reports Second Quarter 2009 Financial Results 53914 20Cogdell Spencer Inc Reports Second Quarter 2009 Financial Results 53914 21Cogdell Spencer Inc Reports Second Quarter 2009 Financial Results 53914 22